Articles
Page 20 of 25
-
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P78
-
Phospho-specific antisera to monitor N-terminal autophosphorylation of cGMP-dependent protein kinase type I
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P74 -
NO/cGMP/pCREB re-activation reverses cognition deficits and attenuates amyloid-β neuropathology in transgenic models of Alzheimer’s disease
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P72 -
Linaclotide induces secretion of cGMP from mouse colonic epithelium
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P70 -
Genetic silencing of sGC β1 in cancer: role of epigenetic regulation
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P66 -
Endothelial dysfunction in a mouse model of human neutral lipid storage disease
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P64 -
Function of cGMP-dependent protein kinase II in volume expansion-induced diuresis
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P63 -
Suppression of kidney fibrosis by cGMP-dependent protein kinase I
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P61 -
In striatum phosphodiesterase 10A is part of a synaptic signalling complex
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P59 -
Soluble guanylyl cyclase mediates concomitant coronary vasodilator and positive inotropic actions of the HNO donor Angeli's salt in the intact rat heart
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P57 -
Platelet inhibitory effects of the NO independent sGC stimulator riociguat (Bay 63-2561)
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P55 -
Protective role of endogenous cardiac natriuretic peptide/GC-A system on the maternal heart during the postpartum period
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P53 -
ANP/GC-A signaling attenuates tissue injury by cisplatin
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P51 -
The effects of super-flux (high performance) dialyzer on the plasma glycosylated pro-B-type natriuretic peptide (proBNP) and glycosylated N-terminal proBNP in end-stage renal disease patients on dialysis
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P47 -
Endothelial dysfunction in adipose triglyceride lipase deficiency: role of perivascular adipose tissue
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P45 -
M-atrial natriuretic peptide and nitroglycerin in experimental acute hypertensive heart failure: differential actions of two cGMP activating therapeutics
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P43 -
Transforming PKA into PKG – a structure-function approach to understand cyclic nucleotide selectivity
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P41 -
Metabolic fate of orally administered cGMP in rats
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P39 -
Nitric oxide regulated cyclic di-GMP signaling
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O37 -
Localization and function of NO-GC in the murine gastrointestinal and lower urinary tract
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P37 -
A bone overgrowth disorder due to a gain-of-function mutation in the kinase homology domain of guanylyl cyclase B, the receptor for CNP
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P35 -
67-kDa laminin receptor and cGMP induced cancer-selective apoptosis
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O33 -
cGMP-dependent kinase 2, Na+/H+ regulatory factor 2, and Na+/H+ exchanger isoform 3 assemble within lipid rafts in murine small intestinal brush border membrane
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O31 -
Cell type-specific knock out models to unravel NO/cGMP signaling in smooth muscle
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O29 -
Urinary cGMP concentrations after exposure to radio-contrast media in patient at risk for contrast media induced nephropathy (CIN) predicts 90-day morbidity and mortality
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P29 -
cGMP-Prkg1 signaling PDE5 inhibition shelter cochlear hair cells and hearing function
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O27 -
Cardiovascular response to NO donors in mice deficient in NO-GC
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P27 -
PDE3 is the major cGMP-PDE in adult mouse ventricular cardiomyocytes
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P26 -
Role of cGMP in fat and metabolism
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O25 -
Guanylyl cyclase-B plays an important role in adipogenesis and “browning” of white fat
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P24 -
Elementary Ca2+signals through endothelial TRPV4 channels regulate vascular function
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O23 -
Thiol-redox proteins interact with soluble guanylyl cyclase and modulate its activity
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O21 -
New mechanisms of normoxic and hypoxic cGMP signalling mediated by the nitrite anion
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O20 -
The soluble guanylyl cyclase stimulator BAY 41-2272 increases differentiation and function of brown adipocytes
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P20 -
Redox signalling by protein kinase G Iα in cardiovascular physiology and pathology
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O19 -
Mechanisms driving heme insertion into apo-sGC during its maturation in cells
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O18 -
The soluble guanylyl cyclase activator BAY 60-2770 ameliorates detrusor dysfunction in obese mice
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P18 -
Targeting native and apo-sGC
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O17 -
A tissue based chemical proteomics screen to identify novel G-kinase associated proteins (GKAPs)
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P16 -
Conformational changes involved in sGC activation
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O12 -
MicroRNA miR-425 is a negative regulator of atrial natriuretic peptide
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O10 -
Identification of protein kinase G I alpha interacting proteins as potential targets to prevent cardiac remodeling
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P10 -
Role of NO-sensitive guanylyl cyclase in angiogenesis and arteriogenesis
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P8 -
Genetic modifiers of hypertension in sGC-deficient mice
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O8 -
Genetic variants in guanylyl cyclase and phoshodiesterase affecting coronary disease risk
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O6 -
What have genome-wide association studies taught us about cGMP and blood pressure regulation?
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O5 -
A possible crosstalk between cGMP pathway and Activin receptor-like kinase 7 (Alk7) in adipocytes
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P4 -
Lessons from tissue-specific KO of CNP/GC-B system - everlasting challenge to clinical application
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O4 -
Abstract not submitted for publication
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O3 -
Chronic natriuretic peptide protein therapeutics
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O1
Annual Journal Metrics
-
2022 Citation Impact
2.9 - 2-year Impact Factor
2.9 - 5-year Impact Factor
0.932 - SNIP (Source Normalized Impact per Paper)
0.603 - SJR (SCImago Journal Rank)2023 Speed
57 days submission to first editorial decision for all manuscripts (Median)
178 days submission to accept (Median)2023 Usage
790,731 downloads
400 Altmetric mentions
Peer-review Terminology
-
The following summary describes the peer review process for this journal:
Identity transparency: Single anonymized
Reviewer interacts with: Editor
Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication